PVLA CIK: 1583648

Palvella Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.66
FY22:
−59.9
FY23:
−13.7
FY24:
−10.8
FY25:
−25.0
Change from FY21 to FY23
millions USD
FY21:
−0.95
FY22:
−21.2
FY23:
12.0
FY24:
–
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
59.1
FY22:
7.21
FY23:
5.00
FY24:
87.1
FY25:
−0.66
millions USD
FY21:
47.3
FY22:
−79.1
FY23:
−8.70
FY24:
76.3
FY25:
−25.6
(positive)
Change from FY21 to FY23
millions USD
FY21:
−8.61
FY22:
−61.0
FY23:
−13.9
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR